EGFR-dependent signalling reduced and p38 dependent apoptosis required by Gallic acid in Malignant Mesothelioma cells

dc.contributor.authorDemiroğlu-Zergeroğlu, Asuman
dc.contributor.authorCandemir, Gulsife
dc.contributor.authorTurhanlar, Ebru
dc.contributor.authorSagir, Fatma
dc.contributor.authorAyvali, Nurettin
dc.date.accessioned2025-10-29T11:30:16Z
dc.date.issued2016
dc.departmentFakülteler, Temel Bilimler Fakültesi, Moleküler Biyoloji ve Genetik Bölümü
dc.description.abstractThe unrestrained EGFR signalling contributes to malignant phenotype in a number of cancers including Malignant Mesotheliomas. Present study was designed to evaluate EGFR-dependent anti-proliferative and apoptotic effects of Gallic acid in transformed Mesothelial (MeT-5A) and Malignant Mesothelioma (SPC212) cells. Gallic acid reduced the viability of Malignant Mesothelioma cells in a concentration and time-dependent manner. However, viability of mesothelial cells reduced only at high concentration and longer time periods. Gallic acid restrained the activation of EGFR, ERK1/2 and AKT proteins and down regulated expression of Cyclin D and Bcl-2 genes, but upregulated the expression of p21 gene in EGF-induced SPC212 cells. GA-induced transitory G1 arrest and triggered mitochondrial and death receptor mediated apoptosis, which requires p38MAPK activation. The data provided here indicate that GA is able to inhibit EGFR dependent proliferation and survival signals and induces p38 pathway dependent apoptosis in Malignant Mesothelioma cells. On the basis of these experimental findings it is worthwhile to investigate further the biological activity of Gallic acid on other Mesothelioma cell lines harbouring aberrant EGFR signals. (C) 2016 Elsevier Masson SAS. All rights reserved.
dc.description.sponsorshipgrant Gebze Institute of Technology (Gebze Technical University) Research Project [BAP-2012-A-03]
dc.description.sponsorshipThis work was supported by grant Gebze Institute of Technology (Gebze Technical University-2014) Research Project BAP-2012-A-03.
dc.identifier.doi10.1016/j.biopha.2016.11.005
dc.identifier.endpage2007
dc.identifier.issn0753-3322
dc.identifier.issn1950-6007
dc.identifier.orcid0000-0002-5826-1305
dc.identifier.orcid0000-0002-4086-8459
dc.identifier.orcid0000-0001-6272-7158
dc.identifier.pmid27847212
dc.identifier.scopus2-s2.0-85002170894
dc.identifier.scopusqualityQ1
dc.identifier.startpage2000
dc.identifier.urihttps://doi.org/10.1016/j.biopha.2016.11.005
dc.identifier.urihttps://hdl.handle.net/20.500.14854/11495
dc.identifier.volume84
dc.identifier.wosWOS:000390438100237
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier France-Editions Scientifiques Medicales Elsevier
dc.relation.ispartofBiomedicine & Pharmacotherapy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20251020
dc.subjectMesothelioma
dc.subjectGallic acid
dc.subjectEGFR
dc.subjectMAPK
dc.subjectAKT
dc.subjectCaspases
dc.titleEGFR-dependent signalling reduced and p38 dependent apoptosis required by Gallic acid in Malignant Mesothelioma cells
dc.typeArticle

Dosyalar